G. Madsen

The Impact of Periodontitis on Inflammatory Bowel Disease Activity.

N. Pandis, J. Burisch, A. Stavropoulos, 2022, Inflammatory Bowel Diseases.

Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study

H. Siebner, J. Seidelin, H. Thomsen, 2022, BMJ Open.

The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases—an international Delphi consensus survey

R. Bryant, J. Burisch, D. Carter, 2022, Alimentary pharmacology & therapeutics.

Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis.

J. Seidelin, F. Bendtsen, J. Burisch, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey

J. Gisbert, B. Barberio, G. Fiorino, 2022, Journal of Crohn's & colitis.

NBOMe hallucinogenic drug exposures reported to the Danish Poison Information Centre.

K. Dalhoff, T. Petersen, G. Madsen, 2017, Danish Medical Journal.